272 related articles for article (PubMed ID: 28823185)
1. Conducting EQ-5D Valuation Studies in Resource-Constrained Countries: The Potential Use of Shrinkage Estimators to Reduce Sample Size.
Chan KKW; Xie F; Willan AR; Pullenayegum EM
Med Decis Making; 2018 Jan; 38(1):26-33. PubMed ID: 28823185
[TBL] [Abstract][Full Text] [Related]
2. Quantifying Parameter Uncertainty in EQ-5D-3L Value Sets and Its Impact on Studies That Use the EQ-5D-3L to Measure Health Utility: A Bayesian Approach.
Pullenayegum EM; Chan KK; Xie F
Med Decis Making; 2016 Feb; 36(2):223-33. PubMed ID: 26139449
[TBL] [Abstract][Full Text] [Related]
3. The Theoretical Relationship between Sample Size and Expected Predictive Precision for EQ-5D Valuation Studies: A Mathematical Exploration and Simulation Study.
Chan KKW; Pullenayegum EM
Med Decis Making; 2020 Apr; 40(3):339-347. PubMed ID: 32428427
[No Abstract] [Full Text] [Related]
4. Underestimation of Variance of Predicted Health Utilities Derived from Multiattribute Utility Instruments.
Chan KK; Xie F; Willan AR; Pullenayegum EM
Med Decis Making; 2017 Apr; 37(3):262-272. PubMed ID: 27216582
[TBL] [Abstract][Full Text] [Related]
5. Capturing Valuation Study Sampling Uncertainty in the Estimation of Health State Utility Values Using the EQ-5D-3L.
Poulimenos S; Round J; Baio G
Med Decis Making; 2024 May; 44(4):393-404. PubMed ID: 38584481
[TBL] [Abstract][Full Text] [Related]
6. Efficient Designs for Valuation Studies That Use Time Tradeoff (TTO) Tasks to Map Latent Utilities from Discrete Choice Experiments to the Interval Scale: Selection of Health States for TTO Tasks.
Che M; Pullenayegum E
Med Decis Making; 2023 Apr; 43(3):387-396. PubMed ID: 36866604
[TBL] [Abstract][Full Text] [Related]
7. Sample size determination for EQ-5D-5L value set studies.
Gandhi M; Xu Y; Luo N; Cheung YB
Qual Life Res; 2017 Dec; 26(12):3365-3376. PubMed ID: 28825183
[TBL] [Abstract][Full Text] [Related]
8. Reducing Uncertainty in EQ-5D Value Sets: The Role of Spatial Correlation.
Shams S; Pullenayegum E
Med Decis Making; 2019 Feb; 39(2):91-99. PubMed ID: 30678526
[TBL] [Abstract][Full Text] [Related]
9. Development of algorithms to estimate EQ-5D and derive health utilities from WHOQOL-HIV Bref: a mapping study.
Castro R; De Boni RB; Perazzo H; Grinsztejn B; Veloso VG; Ribeiro-Alves M
Qual Life Res; 2020 Sep; 29(9):2497-2508. PubMed ID: 32451983
[TBL] [Abstract][Full Text] [Related]
10. Underestimation of uncertainties in health utilities derived from mapping algorithms involving health-related quality-of-life measures: statistical explanations and potential remedies.
Chan KK; Willan AR; Gupta M; Pullenayegum E
Med Decis Making; 2014 Oct; 34(7):863-72. PubMed ID: 24407513
[TBL] [Abstract][Full Text] [Related]
11. Design and sample size considerations for valuation studies of multi-attribute utility instruments.
Shams S; Pullenayegum E
Stat Med; 2020 Oct; 39(23):3074-3104. PubMed ID: 32706130
[TBL] [Abstract][Full Text] [Related]
12. Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist.
Xie F; Gaebel K; Perampaladas K; Doble B; Pullenayegum E
Med Decis Making; 2014 Jan; 34(1):8-20. PubMed ID: 23525701
[TBL] [Abstract][Full Text] [Related]
13. Selecting Health States for EQ-5D-3L Valuation Studies: Statistical Considerations Matter.
Yang Z; Luo N; Bonsel G; Busschbach J; Stolk E
Value Health; 2018 Apr; 21(4):456-461. PubMed ID: 29680103
[TBL] [Abstract][Full Text] [Related]
14. Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients.
Kiadaliri AA; Eliasson B; Gerdtham UG
Health Qual Life Outcomes; 2015 Sep; 13():145. PubMed ID: 26374709
[TBL] [Abstract][Full Text] [Related]
15. Predicting EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities from Older People's Quality of Life Brief Questionnaire (OPQoL-Brief) Scores.
Kaambwa B; Ratcliffe J
Patient; 2018 Feb; 11(1):39-54. PubMed ID: 28623629
[TBL] [Abstract][Full Text] [Related]
16. Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?
Pullenayegum EM; Perampaladas K; Gaebel K; Doble B; Xie F
Eur J Health Econ; 2015 Nov; 16(8):847-55. PubMed ID: 25252970
[TBL] [Abstract][Full Text] [Related]
17. Utility Values for Adults with Unipolar Depression: Systematic Review and Meta-Analysis.
Mohiuddin S; Payne K
Med Decis Making; 2014 Jul; 34(5):666-85. PubMed ID: 24695961
[TBL] [Abstract][Full Text] [Related]
18. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
19. Mapping from the Parkinson's Disease Questionnaire PDQ-39 to the Generic EuroQol EQ-5D-3L: The Value of Mixture Models.
Kent S; Gray A; Schlackow I; Jenkinson C; McIntosh E
Med Decis Making; 2015 Oct; 35(7):902-11. PubMed ID: 25926283
[TBL] [Abstract][Full Text] [Related]
20. Utilities of the EQ-5D: transferable or not?
Knies S; Evers SM; Candel MJ; Severens JL; Ament AJ
Pharmacoeconomics; 2009; 27(9):767-79. PubMed ID: 19757870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
